Follow
Heather Palis
Heather Palis
Verified email at alumni.ubc.ca
Title
Cited by
Cited by
Year
Overdose deaths and the COVID‐19 pandemic in British Columbia, Canada
H Palis, MA Bélair, K Hu, A Tu, J Buxton, A Slaunwhite
Drug and Alcohol Review 41 (4), 912-917, 2022
642022
Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed …
B Nosyk, A Slaunwhite, K Urbanoski, N Hongdilokkul, H Palis, K Lock, ...
BMJ open 11 (6), e048353, 2021
582021
Men’s and women’s response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder
H Palis, K Marchand, D Guh, S Brissette, K Lock, S MacDonald, ...
Substance abuse treatment, prevention, and policy 12, 1-12, 2017
462017
Concurrent use of opioids and stimulants and risk of fatal overdose: a cohort study
H Palis, C Xavier, S Dobrer, R Desai, K Sedgemore, M Scow, K Lock, ...
BMC Public Health 22 (1), 2084, 2022
432022
The relationship between sense of community belonging and self-rated mental health among Canadians with mental or substance use disorders
H Palis, K Marchand, E Oviedo-Joekes
Journal of Mental Health 29 (2), 168-175, 2020
412020
Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study
A Slaunwhite, JE Min, H Palis, K Urbanoski, B Pauly, B Barker, A Crabtree, ...
bmj 384, 2024
392024
Treatment with injectable hydromorphone: comparing retention in double blind and open label treatment periods
E Oviedo-Joekes, H Palis, D Guh, K Marchand, S Brissette, S Harrison, ...
Journal of substance abuse treatment 101, 50-54, 2019
382019
Adverse events during treatment induction with injectable diacetylmorphine and hydromorphone for opioid use disorder
E Oviedo-Joekes, H Palis, D Guh, DC Marsh, S MacDonald, S Harrison, ...
Journal of addiction medicine 13 (5), 354-361, 2019
342019
Risk of cardiovascular diseases in relation to substance use disorders
WQ Gan, JA Buxton, FX Scheuermeyer, H Palis, B Zhao, R Desai, ...
Drug and alcohol dependence 229, 109132, 2021
332021
The role of gender in factors associated with addiction treatment satisfaction among long-term opioid users
K Marchand, H Palis, D Peng, J Fikowski, S Harrison, P Spittal, ...
Journal of addiction medicine 9 (5), 391-398, 2015
332015
Characteristics and response to treatment among indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of …
E Oviedo‐Joekes, H Palis, D Guh, K Marchand, S Brissette, K Lock, ...
Drug and alcohol review 37 (1), 137-146, 2018
232018
Predictors of treatment allocation guesses in a randomized controlled trial testing double-blind injectable hydromorphone and diacetylmorphine for severe opioid use disorder
E Oviedo-Joekes, K Marchand, H Palis, D Guh, S Brissette, K Lock, ...
Addiction Research & Theory 25 (4), 263-272, 2017
182017
Identifying behaviours for survival and wellness among people who use methamphetamine with opioids in British Columbia: a qualitative study
J Corser, H Palis, M Fleury, J Lamb, K Lock, J McDougall, A Mehta, ...
Harm reduction journal 19 (1), 46, 2022
172022
A multi-methods and longitudinal study of patients' perceptions in injectable opioid agonist treatment: Implications for advancing patient-centered methodologies in substance …
K Marchand, H Palis, D Guh, K Lock, S MacDonald, S Brissette, DC Marsh, ...
Journal of Substance Abuse Treatment 132, 108512, 2022
162022
Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report
H Palis, S MacDonald, J Jun, E Oviedo-Joekes
Harm Reduction Journal 18 (1), 57, 2021
162021
Factors associated with perceived abuse in the health care system among long-term opioid users: a cross-sectional study
H Palis, K Marchand, D Peng, J Fikowski, S Harrison, P Spittal, ...
Substance use & misuse 51 (6), 763-776, 2016
162016
Patient perceptions of prejudice and discrimination by health care providers and its relationship with mental disorders: results from the 2012 Canadian community health-mental …
K Marchand, H Palis, E Oviedo-Joekes
Community mental health journal 52, 294-301, 2016
162016
Self‐managing illicit stimulant use: A qualitative study with patients receiving injectable opioid agonist treatment
H Palis, S Harrison, S MacDonald, DC Marsh, MT Schechter, ...
Drug and Alcohol Review 39 (7), 914-923, 2020
152020
Physician communication in injectable opioid agonist treatment: collecting patient ratings with the communication assessment tool
H Palis, K Marchand, S Beaumont, D Guh, S Harrison, S MacDonald, ...
Journal of addiction medicine 14 (6), 480-488, 2020
152020
Association of opioid and stimulant use disorder diagnoses with fatal and nonfatal overdose among people with a history of incarceration
H Palis, W Gan, C Xavier, R Desai, M Scow, K Sedgemore, L Greiner, ...
JAMA Network Open 5 (11), e2243653-e2243653, 2022
142022
The system can't perform the operation now. Try again later.
Articles 1–20